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Abstract. 
 
We have analyzed the role of the protein ki-
nase Chk1 in checkpoint control by using cell-free ex-
 
tracts from 
 
Xenopus
 
 eggs. Recombinant 
 
Xenopus
 
 Chk1 
(Xchk1) phosphorylates the mitotic inducer Cdc25 in 
vitro
 
 
 
on multiple sites including Ser-287. The Xchk1-
catalyzed phosphorylation of Cdc25 on Ser-287 is suf-
ficient to confer the binding of 14-3-3 proteins. Egg
extracts from which Xchk1 has been removed by immu-
nodepletion are strongly but not totally compromised 
in their ability to undergo a cell cycle delay in response 
to the presence of unreplicated DNA. Cdc25 in Xchk1-
depleted extracts remains bound to 14-3-3 due to the 
action of a distinct Ser-287-specific kinase in addition to 
Xchk1. Xchk1 is highly phosphorylated in the presence 
of unreplicated or damaged DNA, and this phosphory-
lation is abolished by caffeine, an agent which attenu-
ates checkpoint control. The checkpoint response to 
unreplicated DNA in this system involves both caf-
feine-sensitive and caffeine-insensitive steps. Our re-
sults indicate that caffeine disrupts the checkpoint 
pathway containing Xchk1.
Key words: Cdc2 • Chk1 • 14-3-3 proteins • Cdc25 • 
caffeine
T
 
he
 
 entry into mitosis is controlled by regulatory
proteins that ensure the proper segregation of repli-
cated chromosomes to daughter cells. The integrity
of chromosomal DNA is under constant surveillance dur-
ing the cell cycle. In eukaryotic cells, when chromosomes
become damaged or cannot be replicated completely, mi-
tosis is prevented by checkpoint mechanisms until two in-
tact copies of the genome can be produced (Hartwell and
Weinert, 1989; Murray, 1995; Elledge, 1996). A key target
of these checkpoint pathways is the Cdc2–cyclin B com-
plex, also known as maturation or M phase–promoting
factor (MPF).
 
1
 
 The Cdc2–cyclin B complex, once activated
at the G2/M transition, phosphorylates a myriad of pro-
teins that carry out the various processes of mitosis such as
nuclear disassembly and chromosome segregation (King
et al., 1994; Morgan, 1997).
In the presence of damaged or unreplicated DNA,
Cdc2–cyclin B is kept inactive due to inhibitory phosphor-
ylation of the Tyr-15 and Thr-14 residues of Cdc2 (Nurse,
1997). These phosphorylations are carried out collectively
by the kinases Wee1 and Myt1 (Featherstone and Russell,
1991; Igarashi et al., 1991; Parker et al., 1992; Mueller et al.,
1995
 
a
 
,
 
b
 
; Watanabe et al., 1995). At the onset of mitosis,
the phosphatase Cdc25C removes these inhibitory phos-
phate groups and thereby activates Cdc2–cyclin B (Dun-
phy and Kumagai, 1991; Gautier et al., 1991; Strausfeld et al.,
1991). The activity of Cdc25C is strictly regulated, being
low during interphase and high at mitosis (Izumi et al.,
1992; Kumagai and Dunphy, 1992). In 
 
Xenopus
 
 egg ex-
tracts, the activation of Cdc25C (hereafter referred to
simply as Cdc25) at mitosis involves the stimulatory phos-
phorylation of its NH
 
2
 
-terminal regulatory domain by at
least two kinases, including Cdc2–cyclin B itself and a
 
Xenopus
 
 homologue of the Polo-like kinase called Plx1
(Hoffmann et al., 1993; Izumi and Maller, 1995; Kumagai
and Dunphy, 1996).
In recent studies in humans and 
 
Xenopus
 
, it has been
shown that Cdc25 is negatively regulated during inter-
phase by the binding of 14-3-3 proteins (Peng et al., 1997;
Kumagai et al., 1998). The inactive form of Cdc25 found
before mitosis is phosphorylated on Ser-216 and Ser-287 in
humans and 
 
Xenopus
 
, respectively. This phosphorylation,
which occurs in a consensus 14-3-3 binding site, mediates
the association between Cdc25 and 14-3-3 proteins. This
phosphorylation-dependent interaction appears to sup-
press the activation and/or action of Cdc25. Mutants of
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Cdc25 that cannot be phosphorylated at this residue and
thus cannot bind 14-3-3 proteins override the unrepli-
cated/damaged DNA checkpoint(s), suggesting that Cdc25
is a target of checkpoint regulation (Peng et al., 1997;
Kumagai et al., 1998).
In fission yeast, the protein kinase Chk1 is required for a
cell cycle arrest in response to damaged DNA and also for
the DNA replication checkpoint under certain circum-
stances (Walworth et al., 1993; al-Khodairy et al., 1994;
Francesconi et al., 1997; Furnari et al., 1997). Chk1 acts
downstream of several Rad gene products and is modified
by phosphorylation upon DNA damage (Carr et al., 1995;
Walworth and Bernards, 1996). Likewise, the kinase
Rad53 from budding yeast is phosphorylated upon DNA
damage in a manner that depends on several checkpoint
control genes (Sanchez et al., 1996; Sun et al., 1996). In
 
Drosophila
 
, the 
 
grapes
 
 gene encodes a Chk1 homologue
that appears to modulate cell cycle timing (Fogarty et al.,
1997; Sibon et al., 1997). It has recently been shown that
fission yeast Chk1 and its human homologue phosphory-
late human Cdc25C on Ser-216, suggesting that Chk1 acts
at least in part by regulating the binding of 14-3-3 to
Cdc25C (Peng et al., 1997; Sanchez et al., 1997).
 
Xenopus
 
 egg extracts have provided a valuable in vitro
system for studying the mechanisms of cell cycle control
(Murray, 1991). Although early 
 
Xenopus
 
 embryos do not
normally manifest the replication and damage check-
points, egg extracts to which DNA has been added exoge-
nously at a concentration typically found in somatic cells
undergo a pronounced cell cycle arrest in response to rep-
lication inhibitors such as aphidicolin or DNA damaging
agents (Dasso and Newport, 1990; Kumagai et al., 1998).
Moreover, caffeine, an agent which disrupts the cell cycle
arrest in either aphidicolin-treated or irradiated mamma-
lian tissue culture cells by an unknown mechanism (Schle-
gel and Pardee, 1986), also overrides the unreplicated/
damaged DNA checkpoint(s) in 
 
Xenopus 
 
egg extracts
(Dasso and Newport, 1990; Kumagai and Dunphy, 1995).
These observations suggest that the protein components
of such checkpoint pathways are stored in a latent form in
unfertilized eggs.
In this report, we have cloned a 
 
Xenopus
 
 Chk1 homo-
logue (Xchk1) and analyzed its role in checkpoint control
in egg extracts. In immunodepletion studies, we have
found that Xchk1 plays a role in the unreplicated/damaged
DNA checkpoint(s) in this system. The phosphorylation of
Cdc25 on Ser-287 by recombinant Xchk1 in vitro is suffi-
cient to confer the binding of 14-3-3 proteins, but there ap-
pears to be an additional kinase with this substrate spe-
cificity in egg extracts. We find that caffeine acts by
disrupting the function of Xchk1. However, a distinct, caf-
feine-insensitive pathway also plays a role in the check-
point response. Taken together, these results indicate that
a major facet of the checkpoint-mediated delay of the cell
cycle in this system involves a caffeine-sensitive pathway
containing Xchk1, Cdc25, and 14-3-3 proteins.
 
Materials and Methods
 
Cloning of a Xenopus Chk1 Homologue (Xchk1)
 
Two degenerate oligonucleotides corresponding to sequences conserved
 
between 
 
Schizosaccharomyces pombe
 
 Chk1 and 
 
Drosophila
 
 Grapes were
designed: TTT(G/C)(A/G)TAAIATIGAICCIGATGTIGG and A(G/A)
IATIATICCICAI(G/C)(A/T)CCAITI(G/A)TCI(A/G)(C/T). A polymer-
ase chain reaction (PCR) using 
 
Xenopus
 
 oocyte cDNA as the template
yielded a major 300-bp fragment in addition to a few minor fragments.
DNA sequencing revealed that the 300-bp fragment encodes a segment of
protein with significant homology to Chk1. The 300-bp fragment was radi-
olabeled with 
 
32
 
P and used to screen a 
 
Xenopus
 
 oocyte cDNA library in
the pAX-NMT vector to obtain a full-length cDNA clone (Mueller et al.,
1995
 
a
 
). A 2.2-kb ApaI-XhoI fragment encoding full-length Xchk1 was
cloned into pBluescript SK- (pBS-Xchk1). A series of deletion clones was
constructed by using the Erase-a-base kit (Promega Corp., Madison, WI).
DNA sequencing of both strands was performed with an ABI model 373
automated sequencer (Perkin-Elmer Corp., Foster City, CA).
 
Production of Recombinant His6–Xchk1 and
His6–Xchk1-N135A Proteins
 
An NcoI site at the start codon of Xchk1 was created by PCR using Pfu
DNA polymerase with the primers CATGCCATGGCAGTTCCG-
TTTGTTGAAG and GGCCCTGGATTTAATCACTTC. The resulting
PCR fragment was digested with NcoI and EcoRV to produce a 400-bp
fragment encoding the NH
 
2
 
-terminal region of Xchk1. This fragment and
a 1.7-kb EcoRV-XhoI fragment encoding the remaining COOH-terminal
portion of Xchk1 were ligated to pFastBacHTa that had been digested
with NcoI and XhoI. The kinase-negative mutant of Xchk1 (N135A) was
created by PCR with the primers GAGATATCAAGCCTGAGGCCT-
TGCTTTTAG and AAACAGCTATGACCATGATTACGCC. This PCR
fragment was digested with EcoRV and XhoI and cloned into pFast-
BacHTa together with 400-bp NH
 
2
 
-terminal NcoI-EcoRV fragment as de-
scribed above. Baculoviruses encoding the recombinant His6–Xchk1 and
His6–Xchk1-N135A proteins were produced using the Bac-to-Bac system
(GIBCO BRL, Gaithersburg, MD). Recombinant proteins were isolated
using nickel agarose beads as described (Kumagai and Dunphy, 1995).
 
Production of GST–Cdc25, GST–Cdc25-S287A,
GST–Cdc25(254–316)-WT, and
GST–Cdc25(254–316)-S287A Proteins in Bacteria
 
The BamHI-HindIII fragment of pFastBacHTa encoding His6–Cdc25-
S287A (Kumagai et al., 1998) was cloned into pGEX–Cdc25 (Kumagai
and Dunphy, 1992) that had been digested with BamHI and HindIII to
yield pGEX–Cdc25-S287A. Glutathione-S-transferase (GST)–Cdc25 and
GST–Cdc25-S287A were purified as described from 
 
Escherichia coli
 
CAG629 transformed with pGEX–Cdc25 and pGEX–Cdc25-S287A, re-
spectively (Kumagai and Dunphy, 1992). GST fusion protein constructs
containing amino acids 254–316 of either wild-type 
 
Xenopus
 
 Cdc25 (GST–
cdc25[254–316]-WT) or its S287A mutant (GST–Cdc25[254-316]-S287A)
were produced by PCR with Pfu DNA polymerase (Stratagene, La Jolla,
CA) using the primers CTAGAGGGATCCATGGCAATTCTTCT-
GTCGGGACCC and GGCCGTCGAATTCACGTCTCCTTTTCAC-
TCTGAC and the appropriate DNA template. The PCR fragments were
digested with BamHI and EcoRI and ligated into pGEX-2T that had been
digested with BamHI and EcoRI. These GST fusion proteins were ex-
pressed in the 
 
E
 
.
 
 coli
 
 strain BL21(DE3)pLysS and purified using glu-
tathione agarose (Smith and Johnson, 1988).
 
Egg Extracts and Isolation of the Nuclear Fraction
 
Xenopus
 
 egg extracts were prepared as described (Murray, 1991). Egg ex-
tracts arrested in interphase due to the presence of unreplicated DNA
routinely contained 1,000–3,000 demembranated 
 
Xenopus
 
 sperm nuclei/
 
m
 
l
of extract and 100 
 
m
 
g/ml aphidicolin. Extracts arrested with damaged
DNA contained 3,000 sperm nuclei/
 
m
 
l that had been treated with ultravio-
let light (UV) as described previously (Kumagai et al., 1998). In some
cases, caffeine was added to a final concentration of 5 mM from a 100-mM
solution freshly dissolved in 10 mM Pipes-KOH, pH 7.5. To isolate the nu-
clear fraction, egg extracts were loaded onto buffer S containing 1.3 M su-
crose, 100 mM KCl, 2.5 mM MgCl
 
2
 
, and 10 mM Hepes-KOH, pH 7.5, and
then centrifuged at 5,000 
 
g
 
 for 2 min in a swinging bucket rotor in an Ep-
pendorf centrifuge (model 5417C; Eppendorf Scientific, Inc., Hamburg,
Germany). The pellets were resuspended gently in 1 ml of buffer S and re-
centrifuged at 5,000 
 
g
 
 for 2 min. For extracts that had been treated with
caffeine, 5 mM of caffeine was included in buffer S.
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Kinase Assays
 
Xchk1 was incubated with full-length His6–Cdc25 or GST–Cdc25(254–
316)-WT in 40 
 
m
 
l of kinase buffer (10 mM Tris-HCl, pH 7.5, 10 mM
MgCl
 
2
 
, and 1 mM DTT) containing 2 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP and 10 
 
m
 
M ATP.
 
Binding of 14-3-3
 
e
 
 Protein to Cdc25
 
Glutathione agarose beads (5 
 
m
 
l) containing either GST–Cdc25-WT,
GST–Cdc25-S287A, or no protein were incubated with 0.3 
 
m
 
g His6–
Xchk1, 0.3 
 
m
 
g His6–Xchk1-N135A, or neither protein in 50 
 
m
 
l of kinase
buffer containing 1 mM cold ATP at 23
 
8
 
C for 30 min under agitation.
Next, 1 
 
m
 
g 
 
Xenopus
 
 His6-14-3-3
 
e
 
 protein (Kumagai et al., 1998), 0.5%
NP-40, and 1 mg/ml ovalbumin were added to the mixture, and the incu-
bation was continued for another 30 min at 4
 
8
 
C. Beads were washed four
times with 10 mM Hepes-KOH, pH 7.5, containing 500 mM NaCl and
0.5% NP-40 and then washed two times with Hepes-buffered saline (HBS;
10 mM Hepes-KOH, pH 7.5, and 150 mM NaCl). Proteins were eluted
from the beads with 5 mM glutathione in HBS.
 
Production of 
 
35
 
S-labeled Xchk1 Protein
 
35
 
S-labeled Xchk1 and Xchk1–N135A proteins were synthesized using
pBS–Xchk1 and pBS–Xchk1-N135A as templates in the TNT in vitro
transcription/translation system (Promega Corp.) in the presence of
[
 
35
 
S]Translabel (ICN Biomedicals, Inc., Irvine, CA). pBS–Xchk1-N135A
was created by cloning the BspMI-XhoI fragment from pFastBacHTa en-
coding His6–Xchk1-N135A into pBS–Xchk1 that had been digested with
BspMI and XhoI. Reticulocyte lysates containing 
 
35
 
S-labeled proteins
were added to egg extracts supplemented with 100 
 
m
 
g/ml of cyclohexi-
mide.
 
Production of Antibodies
 
Polyclonal rabbit antibodies against the purified His6–Xchk1 protein from
insect cells were produced at a commercial facility (Berkeley Antibody
Co., Richmond, CA). Antibodies were affinity-purified with His6–Xchk1
that had been coupled to CNBr-activated Sepharose 4B (Pharmacia Bio-
tech, Inc., Piscataway, NJ). Antibodies against 
 
Xenopus 
 
Cdc25C and 14-
3-3
 
e
 
 were described previously (Kumagai et al., 1998).
 
Depletion of Xchk1 from Egg Extracts
 
M phase extract (170 
 
m
 
l) was incubated with 10 
 
m
 
g of either affinity-puri-
fied Xchk1 antibodies or control rabbit IgG (Zymed Laboratories Inc.,
South San Francisco, CA) bound to 5 
 
m
 
l of Affiprep protein A beads
(Bio-Rad Laboratories, Hercules, CA) at 4
 
8
 
C for 45 min. At the end of
the incubation, the beads were removed by centrifugation. The superna-
tants were treated again with another batch of antibodies under the same
conditions to yield double-depleted extracts.
 
Treatment of Xchk1 with Protein Phosphatase 2A
 
35
 
S-Labeled Xchk1 was added to egg extract containing 1,000 sperm nu-
clei/
 
m
 
l, 100 
 
m
 
g/ml aphidicolin, and 100 
 
m
 
g/ml cycloheximide. The nuclear
fraction was isolated as described above, dissolved in buffer N (10 mM
Hepes-KOH, pH 7.5, 150 mM NaCl, 1% NP-40, 20 mM 
 
b
 
-glycerolphos-
phate, 10 mM MgCl
 
2
 
, 5 mM EGTA, 1 mM orthovanadate, 10 
 
m
 
M phos-
phoserine, 10 
 
m
 
M phosphothreonine, and 10 
 
m
 
M phosphotyrosine) and
centrifuged at 11,700 
 
g 
 
for 5 min to remove insoluble proteins. Xchk1 was
then immunoprecipitated with anti-Xchk1 antibodies bound to Affiprep
protein A beads. Immunoprecipitates were washed once in buffer N con-
taining 1 
 
m
 
M of microcystin, three times in buffer N, and three times in
HBS. Immunoprecipitates were treated with 0.2 U protein phosphatase
2A (Upstate Biotechnology, Inc., Lake Placid, NY) for 30 min at 23
 
8
 
C in
HBS containing 1 mM DTT and 100 
 
m
 
g/ml of bovine serum albumin.
 
Assay of Ser-287–specific Kinase Activity in
Egg Extracts
 
Egg extracts were diluted 40-fold in EB buffer (80 mM 
 
b
 
-glycerolphos-
phate, pH 7.3, 15 mM MgCl
 
2
 
, 20 mM EGTA, and 1 mM DTT). 10 
 
m
 
l of di-
luted extract was incubated with 2 
 
m
 
g of either GST–Cdc25(254–316)-WT
or GST–Cdc25(254–316)-S287A in 20 
 
m
 
l of kinase buffer for 10 min at
23
 
8
 
C. Reactions were terminated with gel sample buffer and subjected to
SDS-PAGE.
 
Results
 
Cloning of a Xenopus Chk1 Homologue (Xchk1)
 
To clone a 
 
Xenopus
 
 Chk1 homologue, we used degenerate
PCR primers to amplify a segment of its complementary
DNA (cDNA). The oligonucleotide primers were de-
signed against homologous regions in the 
 
S
 
.
 
 pombe
 
 Chk1
and 
 
Drosophila
 
 Grapes protein kinases. PCR amplifica-
tion yielded an 
 
z
 
300-bp fragment that was used to isolate
a full-length 
 
Xenopus
 
 oocyte cDNA that encodes a protein
with strong homology to the Chk1 family of protein kinases
(EMBL/GenBank/DDBJ accession number AF053120). The
Figure 1. Sequence align-
ment of Xenopus Chk1
(Xchk1), human Chk1, Dro-
sophila Grapes, and S. pombe
Chk1. Sequences were aligned
using the Prettyplot program.
Identical residues are boxed.
Asterisk, conserved aspar-
agine (N135) residue that is
required for kinase activity;
underline, sequences that
were used to design degener-
ate PCR primers. These se-
quence data are available
from GenBank/EMBL/DDBJ
under accession number
AF053120.
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open reading frame, which is preceded by two in-frame
termination codons, encodes a 474-amino acid polypeptide
(Xchk1) with a predicted 
 
M
 
r
 
 of 54 kD (Fig. 1). Xchk1
shares significant sequence identity with 
 
S
 
.
 
 pombe
 
 Chk1
(28% identical residues) (Walworth et al., 1993; al-Kho-
dairy et al., 1994), 
 
Drosophila
 
 Grapes (45% identical)
(Fogarty et al., 1997; Sibon et al., 1997), and a human
Chk1 homologue (78% identical) (Flaggs et al., 1997;
Sanchez et al., 1997). The kinase domain of Xchk1, which
resides in the NH
 
2
 
-terminal half of the molecule, is the
most similar among species, but there are also several
blocks of highly conserved sequences in its COOH-termi-
nal region.
 
Xchk1 Phosphorylates Cdc25 on Ser-287 and Mediates 
14-3-3 Binding
 
To study the biochemistry of Xchk1, we expressed a histi-
dine-tagged version (His6–Xchk1) in baculovirus-infected
Sf9 insect cells. We also produced a kinase-negative form of
Xchk1 with a mutation in a catalytically essential residue
(His6–Xchk1-N135A). His6–Xchk1 and His6–Xchk1-N135A
could be purified to near homogeneity by chromatography
on nickel agarose (Fig. 2 
 
A
 
). Recombinant His6–Xchk1
phosphorylates 
 
Xenopus
 
 Cdc25 efficiently in vitro (Fig. 2
 
B
 
, lane 1). Thus, it appears that His6–Xchk1 isolated from
baculovirus-infected Sf9 insect cells is catalytically active,
even though these cells were not treated with replication
inhibitors or DNA-damaging agents. Under these condi-
tions, His6–Xchk1 also phosphorylates the S287A mutant
of Cdc25 in which the critical serine in its 14-3-3 binding
site has been changed to alanine (Fig. 2 B, lane 3). In con-
trast, the kinase-negative His6–Xchk1-N135A protein
could not use either the wild-type or S287A form of Cdc25
as a substrate. To characterize the Xchk1-catalyzed
phosphorylation of Cdc25 in greater detail, we isolated the
32P-labeled wild-type and S287A forms of Cdc25 and sub-
jected them to tryptic phosphopeptide analysis (Fig. 2 C).
These mapping studies indicated that His6–Xchk1 phos-
phorylates wild-type Cdc25 on multiple sites in vitro. One
of these sites corresponds to Ser-287, because a single spot
is missing from the tryptic phosphopeptide map of the
32P-labeled Cdc25-S287A mutant. In other experiments,
we showed that His6–Xchk1 phosphorylates a GST fusion
protein containing a small fragment of Cdc25 that includes
the 14-3-3 binding site (GST–Cdc25[254-316]-WT) (Fig. 2
D, lane 1). In contrast, His6–Xchk1 did not phosphorylate
a mutant form of this peptide containing alanine instead of
serine at position 287 (GST–Cdc25[254-316]-S287A) (Fig.
2 D, lane 2).
Figure 2. Xchk1 phosphorylates Cdc25 on Ser-287 and mediates
binding of 14-3-3. (A) Recombinant His6–Xchk1 (lane 1) and
His6–Xchk1-N135A (lane 2) were purified from baculovirus-
infected insect cells, subjected to SDS-PAGE, and then stained
with Coomassie blue. (B) Xchk1 phosphorylates Cdc25 efficiently
in vitro. His6–Xchk1 (lanes 1 and 3) and His6–Xchk1-N135A
(lanes 2 and 4) were incubated with either His6–Cdc25-WT
(lanes 1 and 2) or His6–Cdc25-S287A (lanes 3 and 4) in kinase
buffer containing 10 mM [g-32P]ATP. Reactions were terminated
with gel sample buffer and subjected to SDS-PAGE and autora-
diography. (C) Xchk1 phosphorylates Cdc25 at Ser-287 and other
sites. His6–Cdc25-WT and His6–Cdc25-S287A that had been in-
cubated with His6–Xchk1 in the presence of 10 mM [g-32P]ATP
were processed for tryptic phosphopeptide mapping. Arrows, po-
sition of the peptide containing Ser-287; dots, origins in the lower
left corner of each map. (D) Specific phosphorylation by His6–
Xchk1 of a fragment of Cdc25 containing the 14-3-3 binding site.
GST–Cdc25(254–316)-WT (lane 1) or GST–Cdc25(254–316)-
S287A (lane 2) were incubated with His6–Xchk1 in the presence
of [g-32P]ATP and subjected to SDS-PAGE and autoradiogra-
phy. Arrow, position of the wild-type and mutant GST fusion
proteins. (E) Phosphorylation of Cdc25 by Xchk1 creates a 14-3-3
binding site. Bacterially-expressed GST–Cdc25-WT (lanes 1–3)
and GST–Cdc25-S287A (lane 4) bound to glutathione agarose
were incubated with His6–Xchk1 (lanes 2 and 4), His6–Xchk1-
N135A (lane 3), or neither protein (lane 1) in kinase buffer con-
taining 1 mM ATP at 238C for 30 min. His6–14-3-3e was then
added to the mixture, and the incubation was continued at 48C
for an additional 30 min. At the end of the incubation, proteins
specifically bound to the beads were eluted with glutathione and
subjected to SDS-PAGE and immunoblotting with either anti-
Cdc25 antibodies (top) or anti–14-3-3e antibodies (bottom).
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Previous studies have indicated that the phosphoryla-
tion of Cdc25C on Ser-216 and Ser-287 from humans and
Xenopus, respectively, is necessary for the binding of 14-
3-3 proteins (Peng et al., 1997; Kumagai et al., 1998). To ask
whether the Xchk1-catalyzed phosphorylation of Xenopus
Cdc25 can mediate 14-3-3 binding, we treated bacterially-
expressed GST–Cdc25 and GST–Cdc25-S287A (both bound
to glutathione agarose beads) with His6–Xchk1 and then
added recombinant His6–14-3-3e protein to the reaction.
After reisolating the beads and eluting bound proteins
with glutathione, we found that His6–14-3-3e could associ-
ate specifically with GST–Cdc25 only if GST–Cdc25 had
been phosphorylated previously by His6–Xchk1 (Fig. 2 E,
lanes 1–3). In contrast, His6–14-3-3e did not bind specifi-
cally to the GST–Cdc25-S287A mutant that had been
treated with His6–Xchk1 (Fig. 2 E, lane 4), even though
this incubation led to substantial phosphorylation of GST–
Cdc25-S287A on sites distinct from Ser-287 (Fig. 2, B and
C). Treatment of GST–Cdc25 with the kinase-negative
His6–Xchk1-N135A mutant did not lead to binding of
His6–14-3-3e (Fig. 2 E, lane 3). In conclusion, the phos-
phorylation of Xenopus Cdc25 on Ser-287 by Xchk1 is suf-
ficient for the binding of 14-3-3 proteins.
Immunodepletion of Xchk1 from Egg Extracts
Reveals Xchk1-dependent and Xchk1-independent 
Checkpoint Control Pathways
To investigate the role of Xchk1 in checkpoint control, we
set out to remove this protein from Xenopus egg extracts
by immunodepletion. For this purpose, we used recombi-
nant His6–Xchk1 to generate polyclonal antibodies that
recognize a 54-kD polypeptide in immunoblots of Xeno-
pus egg extracts (Fig. 3 A, lane 1). By using recombinant
His6–Xchk1 as a standard, we estimate that endogenous
Xchk1 is present at a concentration of 2 ng/ml (40 nM) in
egg extracts. By comparison, the concentration of Cdc25C
in these extracts is 10 ng/ml (140 nM) (Kumagai and Dun-
phy, 1992). By subjecting egg extracts to two rounds of
immunodepletion with anti-Xchk1 antibodies bound to
protein A beads, we were able to remove this protein
quantitatively from egg extracts, as determined by immu-
noblotting with anti-Xchk1 antibodies (Fig. 3 A, lane 3).
For comparison, no Xchk1 was removed by a mock immu-
nodepletion with control antibodies (Fig. 3 A, lanes 1 and
2). Xchk1 could be restored to Xchk1-depleted extracts at
close to the physiological level by the addition of recombi-
nant His6–Xchk1 (Fig. 3 A, lane 4).
Next, we compared cell cycle progression and check-
point function in Xchk1-depleted extracts and mock-deple-
ted control extracts. Typically, egg extracts in which a
checkpoint has not been triggered enter mitosis between
75 and 105 min after the activation of the extract with cal-
cium (Fig. 3 B). However, extracts containing both the
replication inhibitor aphidicolin and a sufficient concen-
tration of Xenopus sperm chromatin (.1,000 demembran-
ated sperm nuclei/ml of egg extract) cannot enter mitosis
for more than 3 h (Fig. 3 C). We observed that Xchk1-
depleted extracts treated with aphidicolin entered mitosis
substantially earlier (half-maximal nuclear envelope break-
down at z150 min) than mock-depleted extracts con-
taining aphidicolin. Nonetheless, Xchk1-depleted extracts
treated with aphidicolin were significantly delayed in mi-
totic entry in comparison with Xchk1-depleted extracts
that had not been treated with aphidicolin (Fig. 3, B and
C). Thus, it appears that the presence of unreplicated
DNA can impede the entry into mitosis to some extent in
Xchk1-depleted extracts but not nearly as efficiently as in
mock-depleted extracts that contain Xchk1. Significantly,
when His6–Xchk1 was added back to the Xchk1-depleted
Figure 3. Immunodepletion of Xchk1 compromises checkpoint
control in Xenopus egg extracts. (A) Immunodepletion of Xchk1
from Xenopus egg extracts. An M phase extract (lane 1) was
treated with anti-Xchk1 antibodies (lanes 3 and 4) or control an-
tibodies (lane 2) bound to protein A beads as described in Mate-
rials and Methods. In lane 4, His6–Xchk1 protein was added back
to the Xchk1-depleted extract to a final concentration of 2 ng/ml.
Samples (lanes 1–4) were processed for immunoblotting with
anti-Xchk1 antibodies. (B) Effect of immunodepletion of Xchk1
on egg extracts lacking unreplicated DNA. M phase extracts were
treated with anti-Xchk1 antibodies (d, j) or control antibodies
(m). In one set of samples (j), His6–Xchk1 was added back to a
concentration of 2 ng/ml. The extracts were activated with cal-
cium, and the timing of NEB (nuclear envelope breakdown) was
monitored by microscopy. (C) Effect of immunodepletion of
Xchk1 on egg extracts containing unreplicated DNA. Extracts
that had been treated with either anti-Xchk1 antibodies (d, s,
j) or control antibodies (m, n) were incubated with 1,000 sperm
nuclei/ml and 100 mg/ml aphidicolin in the presence (s, n) or ab-
sence (d, m, j) of 5 mM caffeine. In one case (j), 2 ng/ml His6–
Xchk1 was added back to the Xchk1-depleted extract.
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extracts, treatment with aphidicolin delayed mitotic entry
as effectively as in mock-depleted extracts (Fig. 3 C). This
observation indicates that the compromised checkpoint
control in Xchk1-depleted extracts is due to the absence of
Xchk1 and not to some non-specific effect of the immuno-
depletion procedure. Finally, Xchk1-depleted extracts
lacking aphidicolin entered mitosis z15 min earlier than
mock-depleted extracts or Xchk1-depleted extracts con-
taining exogenously added His6–Xchk1 (Fig. 3 B). Inter-
estingly, Xchk1 immunoprecipitated with anti-Xchk1 anti-
bodies from interphase egg extracts lacking aphidicolin
phosphorylates His6–Cdc25 or GST–Cdc25(254–316) as
efficiently as baculovirus-expressed His6–Xchk1 from Sf9
insect cells (data not shown). Thus, Xchk1 may contribute
to mitotic timing to some extent in the apparent absence
of a checkpoint response.
Caffeine Disrupts the Checkpoint Control Pathway 
That Is Dependent upon Xchk1
Caffeine has been reported to override the replication and
damage checkpoints in various experimental systems, but
its mechanism of action and molecular target(s) have been
unknown (Schlegel and Pardee, 1986; Dasso and Newport,
1990; Kumagai and Dunphy, 1995; Poon et al., 1997). In
Xenopus egg extracts containing unreplicated or damaged
DNA, the inclusion of caffeine overrides the checkpoint-
mediated delay of mitosis. As shown in Fig. 3 C, caffeine
accelerates mitotic entry substantially in mock-depleted
extracts containing aphidicolin. Nonetheless, these caf-
feine-treated extracts enter mitosis at a slower rate than
extracts that lack unreplicated or damaged DNA (Fig. 3 C;
see also Fig. 2 in Kumagai and Dunphy, 1995). However,
the presence of caffeine did not affect mitotic timing in
Xchk1-depleted extracts containing aphidicolin (Fig. 3 C).
In particular, Xchk1-depleted extracts containing aphidi-
colin underwent nuclear envelope breakdown at the same
time in the presence and absence of caffeine. Taken to-
gether, these results indicate that the checkpoint-mediated
delay of mitotic entry involves collaborating Xchk1-
dependent and Xchk1-independent pathways. The Xchk1-
dependent pathway is sensitive to caffeine, whereas the
Xchk1-independent pathway is unaffected by this agent.
14-3-3 Remains Bound to Cdc25 in
Xchk1-depleted Extracts
Since in vitro phosphorylation of Cdc25 on Ser-287 by
Xchk1 is sufficient for the binding of 14-3-3 proteins, we
asked whether 14-3-3 could bind to Cdc25 in extracts lack-
ing Xchk1 (Fig. 4 A). For this purpose, we subjected
Xchk1-depleted and mock-depleted egg extracts to immu-
noprecipitation with antibodies against Xenopus 14-3-3e
and then immunoblotted the resulting immunoprecipitates
with either anti-Cdc25 antibodies or anti–14-3-3e antibod-
ies (to monitor the recovery of 14-3-3e). In particular, M
phase extracts were treated with anti-Xchk1 or control an-
tibodies, driven into interphase by activation with calcium,
and then subjected to immunoprecipitation with anti–14-
3-3e antibodies. For this experiment, we chose to immuno-
deplete Xchk1 from M phase egg extracts because 14-3-3
proteins are not bound to Cdc25 at M phase (Peng et al.,
1997; Kumagai et al., 1998). We observed that the amount
of Cdc25 bound to 14-3-3e in Xchk1-depleted extracts that
had been triggered to enter interphase was similar to that
bound in either mock-depleted extracts or Xchk1-depleted
extracts to which His6–Xchk1 had been added back (Fig. 4
A, lanes 1–3). With the same batch of egg extract, we con-
firmed that 14-3-3e binds to Cdc25 during interphase but
not M phase and that the binding during interphase is sim-
ilar in the presence and absence of unreplicated or dam-
aged DNA (Fig. 4 A, lanes 4–7; Kumagai et al., 1998).
Figure 4. Cdc25 undergoes phosphorylation of Ser-287 and binds
to 14-3-3e in Xchk1-depleted extracts. (A) The 14-3-3e protein
binds to Cdc25 in Xchk1-depleted extracts. The 14-3-3e protein
was immunoprecipitated from a mock-depleted extract (lane 1),
an Xchk1-depleted extract (lane 2), or an Xchk1-depleted extract
supplemented with 2 ng/ml His6–Xchk1 protein (lane 3). For
lanes 4–7, an M phase extract (lane 4) or interphase extracts
(lanes 5–7) containing 1,000 sperm nuclei/ml (lane 5), 3,000 sperm
nuclei/ml and 100 mg/ml aphidicolin (lane 6), or 3,000 UV-dam-
aged sperm nuclei per ml (lane 7) were immunoprecipitated with
anti–14-3-3e antibodies. All extracts contained 100 mg/ml cyclo-
heximide. In all cases, the anti–14-3-3e immunoprecipitates were
subjected to SDS-PAGE and immunoblotting with anti-Cdc25
(top) or anti–14-3-3e (bottom) antibodies. APH, aphidicolin. (B)
Mock-depleted extracts (lanes 1 and 2) and Xchk1-depleted ex-
tracts (lane 3) containing 1,000 sperm nuclei/ml were assayed for
Ser-287–specific kinase activity using either GST–Cdc25(254–
316)-WT (lanes 2 and 3) or GST–Cdc25(254–316)-S287A (lane 1)
as the substrate.
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These findings suggest that a kinase distinct from Xchk1
can phosphorylate Ser-287 on Cdc25 in Xchk1-depleted
extracts and thereby create a 14-3-3 binding site within
Cdc25. To address this possibility more directly, we used
the GST–Cdc25(254–316)-WT substrate to measure total
Ser-287–specific kinase activity in both mock-depleted and
Xchk1-depleted interphase extracts (Fig. 4 B). We ob-
served that GST–Cdc25(254–316)-WT became phosphory-
lated quite efficiently in the Xchk1-depleted extract (Fig. 4
B, lane 3). The level of phosphorylation was z80% of that
observed in a mock-depleted extract, as quantitated with a
phosphorimager (Fig. 4 B, lane 2). This assay appears to
detect phosphorylation of Ser-287 specifically because the
GST–Cdc25(254–316)-S287A mutant was not radiolabeled
under these conditions (Fig. 4 B, lane 1).
Exogenous Addition of Active Xchk1 Delays Mitosis in 
Egg Extracts in a Caffeine-resistant Manner
As another approach to assess the role of Xchk1 in mitotic
timing, we added extra Xchk1 protein exogenously to cy-
cling Xenopus egg extracts (Fig. 5). For this experiment,
we added active His6–Xchk1 or the catalytically-inactive
His6–Xchk1-N135A mutant to egg extracts at a final con-
centration of 10 ng/ml. Since the endogenous concentra-
tion of Xchk1 in these extracts is 2 ng/ml, this procedure
leads to a sixfold increase in the level of Xchk1. We ob-
served that the wild-type His6–Xchk1 protein elicited a
substantial 60-min delay of mitosis (Fig. 5). In contrast, the
kinase-negative His6–Xchk1-N135A protein had no effect
on the timing of nuclear envelope breakdown (Fig. 5). Par-
enthetically, kinase-negative His6–Xchk1-N135A also had
no effect on the cell cycle delay in aphidicolin-treated ex-
tracts, indicating that this mutant protein does not act as a
dominant-negative competitor of checkpoint regulatory
factors under these conditions (data not shown).
As described above, Xchk1-mediated checkpoint con-
trol is sensitive to caffeine. Therefore, we asked whether
the delay of mitosis elicited by exogenously added His6–
Xchk1 would be affected by this agent. As shown in Fig. 5,
the presence of caffeine did not reverse the inhibitory ef-
fect of exogenously added His6–Xchk1 on the timing of
mitosis. In similar experiments, treatment with caffeine
did accelerate the entry into mitosis in aphidicolin-treated
extracts containing only endogenous Xchk1 (refer to Fig. 3
C). These results suggest that caffeine does not directly in-
hibit the kinase activity of Xchk1. To address this issue
more directly, we assayed the kinase activity of His6–
Xchk1 toward recombinant Cdc25 in the presence and ab-
sence of 5 mM of caffeine. These assays were performed in
the presence of 1 mM ATP, which is the endogenous con-
centration of ATP in egg extracts. We observed that caf-
feine had no effect on either the phosphorylation of Cdc25
by Xchk1 or the in vitro autophosphorylation of Xchk1
(data not shown). Collectively, our results suggest that caf-
feine does not directly inhibit Xchk1 or its downstream ef-
fects but instead compromises some process upstream of
Xchk1 that is required for proper checkpoint regulation.
Caffeine Blocks the Checkpoint-dependent 
Phosphorylation of Xchk1
To further explore the functional properties of Xchk1, we
examined the modification of this protein in the presence
and absence of unreplicated or damaged DNA. For these
experiments, we first prepared 35S-labeled Xchk1 protein
and added it to egg extracts containing either aphidicolin
or UV-damaged sperm chromatin. We observed that a
portion of the labeled Xchk1 protein underwent an obvi-
ous modification in extracts containing unreplicated or
damaged DNA, as evidenced by a decrease of electro-
phoretic mobility in SDS gels (Fig. 6 A, top, lanes 2 and 4).
Similar results were obtained by immunoblotting the en-
dogenous Xchk1 in egg extracts with anti-Xchk1 antibod-
ies (data not shown). This modification appears to be
phosphorylation, since it is reversed by treatment with
protein phosphatase 2A (Fig. 6 B). Typically, we observed
two closely spaced phosphorylated bands with reduced
electrophoretic mobility in comparison with the major 54-kD
Xchk1 band that was found in extracts lacking damaged or
unreplicated DNA (Fig. 6 A, top, lane 1). When the nu-
clear fraction was isolated from these extracts, a higher
proportion of the nuclear Xchk1 protein appeared to be
modified in comparison with Xchk1 in the whole egg
extract (Fig. 6 A, bottom, lanes 2 and 4). Significantly,
caffeine completely abolished the checkpoint-associated
phosphorylation of Xchk1 in the presence of either unrep-
licated or damaged DNA (Fig 6 A, top and bottom, lanes 3
and 5). This observation also argues that caffeine modu-
lates the regulatory pathway containing Xchk1. Since only
a portion of Xchk1 is hyperphosphorylated in response to
unreplicated or damaged DNA and this hyperphosphory-
lated form proved to be difficult to isolate by immunopre-
cipitation, it is unclear at this time whether this phosphory-
lation directly alters the kinase activity of Xchk1.
To characterize further the phosphorylation of Xchk1,
we asked whether it might be due to autophosphorylation
or to the action of a distinct kinase. For these studies, we
added 35S-labeled Xchk1 or the kinase-negative Xchk1–
N135A mutant to either Xchk1-depleted or mock-deple-
ted egg extracts that contained either UV-damaged or un-
damaged sperm chromatin (Fig. 6 C). As expected, the
labeled Xchk1 protein underwent phosphorylation (up-
Figure 5. Exogenously added His6–Xchk1 delays mitosis in egg
extracts in a caffeine-resistant manner. (A) His6–Xchk1 (d, m),
His6–Xchk1-N135A (j), or buffer only (s) was added to egg ex-
tracts containing 1,000 sperm nuclei/ml in the presence (m) or ab-
sence (d, j, s) of 5 mM caffeine. The timing of NEB was moni-
tored by microscopy. Recombinant Xchk1 proteins were added
to a final concentration of 10 ng/ml. Typically, caffeine did not af-
fect mitotic timing significantly in the extracts containing buffer
only or His6–Xchk1-N135A.
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shift in SDS gels) in the extract containing damaged DNA
but not in one containing undamaged DNA (Fig. 6 C).
Similar results were obtained in extracts from which the
endogenous Xchk1 protein had been removed by immu-
nodepletion with anti-Xchk1 antibodies (Fig. 6 C, lanes 3
and 4). In extracts containing the 35S-labeled kinase-nega-
tive Xchk1–N135A protein, we observed somewhat differ-
ent results. Although Xchk1–N135A was clearly modified
in the presence of damaged DNA, the extent of the modi-
fication was reduced. In particular, the most highly phos-
phorylated form of Xchk1 was absent (Fig. 6 C, lanes 6
and 8). Since this partially phosphorylated form of Xchk1–
N135A was also found in Xchk1-depleted extracts, this
phosphorylation is presumably due to the action of a dis-
tinct kinase rather than autophosphorylation. However,
since production of the most highly phosphorylated form
of Xchk1 does depend upon the presence of catalytically
active Xchk1, a portion of the checkpoint-induced modifi-
cation of Xchk1 may represent autophosphorylation.
Discussion
In this report, we have analyzed the biochemical proper-
ties of the Xenopus Chk1 protein kinase (Xchk1) and its
role in checkpoint control in Xenopus egg extracts. Re-
combinant Xchk1 phosphorylates the mitotic regulatory
phosphatase Cdc25 on the critical serine (residue 287) in
its 14-3-3 binding motif as well as some additional un-
defined sites. The Xchk1-catalyzed phosphorylation of
Cdc25 on Ser-287 confers upon Cdc25 the ability to bind
14-3-3 proteins. In particular, Cdc25 that has been phos-
phorylated by Xchk1 in vitro binds efficiently to a recom-
binant form of 14-3-3e, which is the major physiological
partner of Cdc25 during interphase in Xenopus egg ex-
tracts (Kumagai et al., 1998). As described previously, the
binding of 14-3-3 proteins correlates with negative regula-
tion of the mitosis-inducing function of Cdc25C (Peng et al.,
1997; Kumagai et al., 1998).
Various observations suggest that Xchk1 plays a signifi-
cant role in the control of mitotic timing in Xenopus egg
extracts. First, the addition of recombinant Xchk1 to egg
extracts results in a strong inhibition of mitotic entry,
whereas a kinase-negative form of Xchk1 has no effect.
Secondly, immunodepletion of Xchk1 strongly compro-
mises the ability of egg extracts to undergo a cell cycle ar-
rest in response to the presence of unreplicated DNA.
These two effects are consistent with a physiological role
for Xchk1 in negatively regulating Cdc25. Finally, Xchk1
undergoes a marked phosphorylation in the presence of
unreplicated or damaged DNA. This phosphorylation is
abolished by caffeine under conditions in which this agent
overrides checkpoint controls.
Overall, our results indicate that Xenopus egg extracts
possess checkpoint regulatory molecules similar to those
present in yeast and mammals (Carr, 1996; Nurse, 1997;
Rhind et al., 1997; Saka et al., 1997; Sanchez et al., 1997;
Weinert, 1997; Westphal, 1997). By analyzing Xchk1 and
Cdc25 in egg extracts, we have learned about the com-
plexity of the pathway that controls Cdc25 (Fig. 7). For
example, Cdc25 can still associate with 14-3-3 proteins in
extracts from which Xchk1 has been removed by immu-
nodepletion, indicating that a kinase distinct from Xchk1
can phosphorylate Ser-287 of Cdc25. The identity of this
kinase is presently unknown. A human kinase called
C-TAK1 (Cdc twenty-five C–associated protein kinase 1)
can phosphorylate Cdc25C on its 14-3-3 binding site in
Figure 6. Xchk1 is modified when the DNA replication and
DNA damage checkpoints are activated. (A) 35S-labeled Xchk1
was incubated in interphase egg extracts containing 3,000 sperm
nuclei/ml (lane 1), 3,000 UV-damaged sperm nuclei/ml (lanes 2
and 3), or 3,000 sperm nuclei/ml and 100 mg/ml aphidicolin (lanes
4 and 5) in the presence (lanes 3 and 5) or absence (lanes 1, 2, and
4) of 5 mM caffeine. After 100 min of incubation at 238C, 2 ml of
each extract was taken for SDS-PAGE and autoradiography
(top). Alternatively, 50 ml of each extract was centrifuged
through a sucrose solution to isolate the nuclear fraction (bot-
tom), which was also subjected to SDS-PAGE and autoradiogra-
phy. APH, aphidicolin. (B) 35S-labeled Xchk1 was immunopre-
cipitated from interphase extracts containing 3,000 sperm nuclei/
ml and 100 mg/ml aphidicolin. The immunoprecipitates were incu-
bated in phosphatase buffer containing no addition (lane 1), pro-
tein phosphatase 2A (lane 2), or protein phosphatase 2A and 3
mM okadaic acid (lane 3). PP2A, protein phosphatase 2A; OA,
okadaic acid. (C) 35S-labeled Xchk1 (lanes 1–4) and Xchk1–
N135A (lanes 5–8) were incubated for 100 min in either control-
depleted (lanes 1, 2, 5, and 6) or Xchk1-depleted (lanes 3, 4, 7,
and 8) extracts in the presence of either 3,000 sperm nuclei/ml
(lanes 1, 3, 5, and 7) or 3,000 UV-damaged sperm nuclei/ml (lanes
2, 4, 6, and 8). Nuclear fractions were isolated as described above
and subjected to SDS-PAGE and autoradiography.
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vitro, but the role of this enzyme in Cdc25C regulation in
vivo has not been established (Peng et al., 1998). Similarly,
it has been shown that the fission yeast kinase Cds1 over-
laps functionally with Chk1 (Boddy et al., 1998). We have
also found the pathway containing Xchk1, although it
plays a major role in the checkpoint arrest in response to
unreplicated/damaged DNA, does not appear to be fully
responsible. In particular, Xchk1-depleted extracts con-
taining unreplicated DNA, although strongly compro-
mised in their checkpoint response, nonetheless enter mi-
tosis at a significantly delayed rate relative to control
extracts. This observation suggests that the checkpoint ar-
rest involves both Xchk1-dependent and Xchk1-indepen-
dent pathways, which appear to collaborate in the control
of mitotic timing.
Caffeine has been a useful tool in discerning the exist-
ence of these collaborating pathways (Schlegel and Par-
dee, 1986; Dasso and Newport, 1990; Poon et al., 1997).
Furthermore, our studies have provided the first molecular
insight into how this simple compound disrupts checkpoint
regulation. Caffeine overrides the unreplicated/damaged
DNA checkpoint in Xenopus extracts, but nonetheless caf-
feine-treated extracts enter mitosis more slowly than con-
trol extracts in which a checkpoint has not been triggered.
This observation could mean that caffeine is not fully ef-
fective at inhibiting its target(s) or that the checkpoint re-
sponse involves multiple interacting pathways, not all of
which are sensitive to caffeine. Our results favor the latter
possibility because the attenuated cell cycle delay ob-
served in Xchk1-depleted extracts containing unreplicated
or damaged DNA is completely insensitive to caffeine. In
contrast, extracts containing the normal amount of endog-
enous Xchk1 and unreplicated DNA enter mitosis at a
considerably accelerated pace in the presence of caffeine.
This observation, coupled with the fact that caffeine com-
pletely abolishes the checkpoint-dependent phosphoryla-
tion of Xchk1, argues that the Xchk1-dependent pathway
in Xenopus egg extracts is caffeine sensitive. Caffeine ap-
pears not to directly inhibit Xchk1, since it does not block
the phosphorylation of Cdc25 by recombinant Xchk1 in
vitro at a physiological concentration of ATP. Also, caf-
feine does not override the delay of mitosis in egg extracts
in response to the exogenous addition of active recombi-
nant His6–Xchk1. Our results suggest that caffeine acts at
some point upstream of Xchk1. This view is supported by
the observation that the checkpoint-associated phosphory-
lation of Xchk1 is blocked entirely by caffeine.
Much remains to be learned about the biochemical de-
tails of how Xchk1 inhibits mitosis when unreplicated
DNA is present. Earlier studies have indicated that muta-
tion of the 14-3-3 binding site in Cdc25C strongly compro-
mises G2 checkpoint control (Peng et al., 1997; Kumagai
et al., 1998). For example, Xenopus egg extracts containing
unreplicated or damaged DNA and the Cdc25–S287A mu-
tant that lacks a 14-3-3 binding site enter mitosis at ap-
proximately the same time as control extracts in which a
checkpoint has not been triggered (Kumagai et al., 1998).
This observation indicates that the checkpoint response is
strongly compromised when 14-3-3 proteins cannot bind
to Cdc25, although it is not known whether checkpoint
control is totally abolished under these circumstances. In
Xchk1-depleted extracts, the checkpoint defect is less se-
vere, most probably at least in part because another kinase
in egg extracts can also phosphorylate Ser-287 of Cdc25.
Intriguingly, the amount of 14-3-3 bound to Cdc25 is the
same in the absence and presence of unreplicated/dam-
aged DNA (Kumagai et al., 1998). Furthermore, as shown
here, 14-3-3 proteins remain bound to Cdc25 in Xchk1-
depleted extracts, despite the fact that checkpoint control
is clearly disrupted in such extracts. These observations
might appear to be inconsistent with the concept that
binding of 14-3-3 to Cdc25 causes extracts containing un-
replicated/damaged DNA to arrest in interphase. The af-
finity of 14-3-3 for a target with a single binding site should
allow dynamic binding and dissociation of these molecules
(Yaffe et al., 1997). Thus, it will be critical to determine
the rate of phosphorylation and dephosphorylation of Ser-
287 on Cdc25 in the absence and presence of unreplicated/
damaged DNA. On the other hand, it seems possible that,
although binding of 14-3-3 to Cdc25 may be important for
proper checkpoint control, this interaction may not be the
whole explanation for checkpoint regulation. In this re-
gard, it is intriguing that Xchk1 phosphorylates Cdc25 in
vitro at sites that apparently do not confer 14-3-3 binding.
It will be important to determine whether these phosphor-
ylations occur at sites on Cdc25 that are phosphorylated in
vivo and, if so, to determine their role in the regulation of
Cdc25. In addition to the possibility that Xchk1 could reg-
ulate Cdc25 by phosphorylating sites distinct from Ser-287,
Xchk1 could possess an additional target(s) besides Cdc25.
For example, O’Connell et al. (1997) have proposed that
Wee1 is a target of Chk1 in fission yeast.
Xchk1 undergoes a marked phosphorylation in the pres-
ence of either unreplicated or damaged DNA. This finding
could mean that Xchk1 responds to both the replication
and damage checkpoints in Xenopus egg extracts. How-
ever, it is possible that some of the DNA in aphidicolin-
treated nuclei may undergo damage. Likewise, it is quite
likely that sites of damage in UV-treated nuclei would im-
pede the progression of replication forks. Nonetheless, the
Figure 7. Model for checkpoint regulation in Xenopus egg ex-
tracts. Refer to text for details.
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phosphorylation of Xchk1 correlates well with the cell cy-
cle delay that is imposed when unreplicated or damaged
DNA is present. In principle, the checkpoint-dependent
phosphorylation of Xchk1 could elicit increased kinase ac-
tivity toward Cdc25, but technical difficulties in isolating
Xchk1 in its fully phosphorylated form have thus far pre-
cluded an answer to this question. Alternatively, this phos-
phorylation could potentiate the action of Xchk1 by some
other mechanism such as controlling its intracellular local-
ization or protein–protein interactions. Finally, it is possi-
ble that the hyperphosphorylation of Xchk1 is not causally
responsible for Xchk1-mediated cell cycle delay.
The checkpoint-specific phosphorylation of Xchk1 ap-
pears to involve both autophosphorylation and the action
of a distinct kinase. The kinase-negative Xchk1–N135A
mutant clearly becomes phosphorylated in Xchk1-deple-
ted extracts containing unreplicated or damaged DNA, in-
dicating that this phosphorylation cannot be due to either
inter- or intramolecular autophosphorylation. However,
the wild-type Xchk1 protein is more extensively phospho-
rylated in the presence of unreplicated or damaged DNA
in both control and Xchk1-depleted extracts, suggesting
that autophosphorylation may also be involved. The ki-
nase(s) that phosphorylates Xchk1 is unknown, but studies
in fission yeast have implicated the protein kinase Rad3 in
the regulation of Chk1 (al-Khodairy et al., 1994; Bentley et
al., 1996; Walworth and Bernards, 1996). Rad3 is a mem-
ber of the DNA-dependent protein kinase family with ho-
mologues known as ATM and ATR in mammals (Paulo-
vich and Hartwell, 1995; Keegan et al., 1996; Carr, 1997;
Flaggs et al., 1997; Westphal, 1997; Cliby et al., 1998). Xe-
nopus homologues of ATM and ATR have not been de-
scribed, but these proteins could potentially be involved
either directly or indirectly in the checkpoint-associated
phosphorylation of Xchk1.
In conclusion, we have shown that Xchk1 phosphory-
lates Ser-287 of Xenopus Cdc25, thereby allowing 14-3-3
proteins to associate with this activator of Cdc2. Xchk1 ap-
pears to play an important role in mitotic timing in egg ex-
tracts: Xchk1-depleted extracts are compromised in their
checkpoint responsiveness and exogenous addition of ac-
tive Xchk1 can delay mitosis substantially even in the ab-
sence of unreplicated or damaged DNA. Nonetheless,
Xchk1 does not account fully for the phosphorylation of
Cdc25 on Ser-287, since binding of 14-3-3 to Cdc25 is not
diminished in Xchk1-depleted extracts. The checkpoint
response of egg extracts to unreplicated DNA appears to
involve both Xchk1-dependent (caffeine-sensitive) and
Xchk1-independent (caffeine-insensitive) pathways. The
nature of the caffeine-insensitive, Xchk1-independent
pathway remains to be determined. In principle, it could
involve either the Ser-287–specific kinase that is distinct
from Xchk1 or some other facet of Cdc2 regulation.
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